Investigation and management of an outbreak of multidrug-carbapenem-resistant Acinetobacter baumannii in Cambridge, UK

Journal of Hospital Infection

Volumn 70, Issue 2, 2008, Pages 109-118

  Enoch, D A ^a   Summers, C ^a   Brown, N M ^a   Moore, L ^a   Gillham, M I ^a   Burnstein, R M ^a   Thaxter, R ^a   Enoch, L M ^a   Matta, B ^a   Sule, O ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Carbapenems; Hospital infection; Multidrug resistant Acinetobacter baumannii

Indexed keywords

CARBAPENEM; COLISTIN; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM CONTAMINATION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BRAIN VENTRICULITIS; CLEANING; CLINICAL ARTICLE; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; ENDEMIC DISEASE; ENVIRONMENTAL SANITATION; EPIDEMIC; FEMALE; HAND WASHING; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; INTERDISCIPLINARY COMMUNICATION; INTRACRANIAL PRESSURE MONITORING; MALE; MORTALITY; MULTIDRUG RESISTANCE; PERSONAL HYGIENE; SCREENING TEST; TREATMENT RESPONSE; UNITED KINGDOM;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CARBAPENEMS; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GREAT BRITAIN; HOSPITALS, TEACHING; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED;

EID: 50849101637     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2008.05.015     Document Type: Article

References (25)

1. Wendt C., Dietz B., Dietz E., and Ruden H. Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol 35 (1997) 1394-1397
2. Turton J.F., Kauffman M.E., Warner M., et al. A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England. J Hosp Infect 58 (2004) 170-179
3. Coelho J.M., Turton J.F., Kaufmann M.E., et al. Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England. J Clin Microbiol 44 (2006) 3623-3627
4. Roberts S.A., Findlay R., and Lang S.D. Investigation of an outbreak of multi-drug resistant Acinetobacter baumannii in an intensive care burns unit. J Hosp Infect 48 (2001) 228-232
5. Melamed R., Greenberg D., Porat N., et al. Successful control of an Acinetobacter baumannii outbreak in a neonatal intensive care unit. J Hosp Infect 53 (2003) 31-38
6. Wang S.H., Sheng W.H., Chang Y.Y., et al. Healthcare-associated outbreak due to pan-drug resistant Acinetobacter baumannii in a surgical intensive care unit. J Hosp Infect 53 (2003) 97-102
7. Pimentel J.D., Low J., Styles K., Harris O.C., Hughes A., and Athan E. Control of an outbreak of multi-drug-resistant Acinetobacter baumannii in an intensive care unit and a surgical ward. J Hosp Infect 59 (2005) 249-253
8. Andrews J.M., and for the BSAC Working Party on Susceptibility Testing. BSAC standardized disc susceptibility testing method (version 5). J Antimicrob Chemother 58 (2006) 511-529
9. Corbella X., Montero A., Pujol M., et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 38 (2000) 4086-4095
10. Garcia-Garmendia J.L., Ortiz-Leyba C., Garnacho-Montero J., et al. Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. Clin Infect Dis 33 (2001) 939-946
11. Cisneros J.M., Rodriguuez-Bano J., Fernanedez-Cuenca F., et al., . on behalf of the Spanish Group for Nosocomial Infection (GEIH) for the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study. Clin Microbiol Infect 11 (2005) 874-879
12. del Mar Tomas M., Cartelle M., Pertega S., et al. Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection. Clin Microbiol Infect 11 (2005) 540-546
13. Aygun G., Demirkiran O., Utku T., et al. Environmental contamination during a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit. J Hosp Infect 52 (2002) 259-262
14. El Shafie S.S., Alishaq M., and Leni Garcia M. Investigation of an outbreak of multidrug-resistant Acinetobacter baumannii in trauma intensive care unit. J Hosp Infect 56 (2004) 101-105
15. Denton M., Wilcox M.H., Parnell P., et al. Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit. J Hosp Infect 56 (2004) 106-110
16. McDonald L.C., Walker M., Carson L., et al. Outbreak of Acinetobacter spp. bloodstream infections in a nursery associated with contaminated aerosols and air conditioners. Pediatr Infect Dis J 17 (1998) 716-722
17. Akalin H., Ozakin C., and Gedikoglu S. Epidemiology of Acinetobacter baumannii in a university hospital in Turkey. Infect Control Hosp Epidemiol 27 (2006) 404-408
18. Levin A.S., Barone A.A., Penco J., et al. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 28 (1999) 1008-1011
19. Garnacho-Montero J., Ortiz-Leyba C., Jimenez-Jimenez F.J., et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis 36 (2003) 1111-1118
20. Linden P.K., Kusne S., Coley K., Fontes K., Kramer D.J., and Paterson D. Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin Infect Dis 37 (2003) e154-e160
21. Markou N., Apostolakos H., Koumoudiou C., et al. Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care 7 (2003) R78-R83
22. Michalopoulos A.S., Tsiodras S., Rellos K., Mentzelopoulos S., and Falagas M.E. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect 11 (2005) 115-121
23. Reina R., Estenssoro E., Saenz G., et al. Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study. Intensive Care Med 31 (2005) 1058-1065
24. Koomanachai P., Tiengrim S., Kiratisin P., and Thamlitikul V. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand. Int J Infect Dis 11 (2007) 402-406
25. Stone S.P., Cooper B.S., Kibbler C.C., et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. J Antimicrob Chemother 59 (2007) 833-840